A Deep Differential Analysis in Four Subtypes of Breast Cancer Based on Regulations of miRNA-mRNA

Tao Huang1, Ling Guo1, Weiyuan Ma2

  • 1Department of Electrical Engineering, Northwest Minzu University, Lanzhou, China.

IET Systems Biology
|June 11, 2025
PubMed

Insights

This study reveals significant differences in gene regulation across breast cancer subtypes. A novel method accurately predicts microRNA-messenger RNA interactions, improving upon traditional approaches.

Area of Science:

  • Oncology
  • Bioinformatics
  • Genomics

Background:

  • Breast cancer is a heterogeneous disease classified into four subtypes.
  • Commonly differentially expressed genes are often overlooked, despite varying regulatory associations among subtypes.
  • Understanding subtype-specific gene regulation is crucial for targeted therapies.

Purpose of the Study:

  • To perform a deep differential analysis of gene expression across four breast cancer subtypes.
  • To investigate the regulatory associations of common differentially expressed genes.
  • To develop a novel method for predicting microRNA-mRNA regulatory networks specific to each breast cancer subtype.

Main Methods:

  • Classified breast cancer subtypes using Prediction Analysis of Microarray 50.
  • Identified common differentially expressed genes using the EdgeR method.
  • Constructed miRNA-mRNA bipartite networks and predicted regulations using a weighted similarity information (WSI) method.

Main Results:

  • Developed a novel method for predicting miRNA-mRNA regulations in breast cancer subtypes.
  • Achieved an 85% accuracy rate for predicted regulations against the miRWalk2.0 database.
  • Demonstrated a 30% improvement in prediction accuracy compared to traditional methods.

Conclusions:

  • The proposed deep differential analysis and WSI method effectively capture subtype-specific miRNA-mRNA regulatory differences.
  • This approach offers a significant advancement in understanding breast cancer heterogeneity and developing targeted strategies.
  • The findings provide a valuable resource for future breast cancer research and therapeutic development.